PofoliaShared via Pofolia

International Journal of Gynecological Cancer· 2020Q1

ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

Nicole Concin, Xavier Matías‐Guiu, Ignace Vergote, David Cibula et al.

Short summary

Updated evidence-based guidelines for endometrial carcinoma management have been developed by leading European oncology, radiotherapy, and pathology societies to improve patient care.

AI-generated from the title and abstract; the full text is not read.

Key points

  • Updated guidelines for endometrial carcinoma management.
  • Developed by ESGO, ESTRO, and ESP.
  • Covers new topics and recent literature.
  • Aims to improve quality of care.

AI-generated from the title and abstract; the full text is not read.

Abstract

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.

The authors' abstract, as published at the source. International Journal of Gynecological Cancer, 2020 · DOI ↗

TakeawaysPremium
Ask the paperFree account

Continue with a free account

Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.

Continue free on the web

Sign in with Google or Apple; no card needed. You come back to this paper.

On your phone:

Field: Obstetrics and Gynecology

Obstetrics and GynecologyMedicine